Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fielding

Showing results (131-140 of 166) with videos related to

Pageof 17
Sort By:
Hemasphere|February 27, 2023
A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient CareTarec Christoffer El-Galaly, Verena I Gaidzik, Mihnea-Alexandru Gaman, et al.
American Journal of Hematology|April 3, 2024
Pre-B acute lymphoblastic leukemia presenting with NPM1 and FLT3 mutationsAlesia A Khan, Daniel James, Vibeke Andresen, et al.
Blood Advances|October 25, 2019
Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemiaNicola Gökbuget, Hagop M Kantarjian, Monika Brüggemann, et al.
Blood|October 13, 2006
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 studyAdele K Fielding, Susan M Richards, Rajesh Chopra, et al.
Bone Marrow Transplantation|February 26, 2014
Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHDF L Dignan, S Aguilar, J J Scarisbrick, et al.
Bone Marrow Transplantation|September 20, 2011
Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHDF L Dignan, D Greenblatt, M Cox, et al.
Haematologica|August 4, 2009
Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remissionBella Patel, Keiren E Kirkland, Richard Szydlo, et al.
Hemasphere|June 7, 2024
Results from UKALL60+, a phase 2 study in older patients with untreated acute lymphoblastic leukemiaBela Patel, Amy A Kirkwood, Clare J Rowntree, et al.
Blood Advances|October 1, 2020
CD1a is rarely expressed in pediatric or adult relapsed/refractory T-ALL: implications for immunotherapySarah Leong, Sarah Inglott, Foteini Papaleonidopoulou, et al.
Haematologica|September 3, 2016
International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemiaNicola Gökbuget, Hervè Dombret, Jose-Maria Ribera, et al.
Pageof 17

Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
Hemasphere|February 27, 2023
A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient CareTarec Christoffer El-Galaly, Verena I Gaidzik, Mihnea-Alexandru Gaman, et al.
American Journal of Hematology|April 3, 2024
Pre-B acute lymphoblastic leukemia presenting with NPM1 and FLT3 mutationsAlesia A Khan, Daniel James, Vibeke Andresen, et al.
Blood Advances|October 25, 2019
Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemiaNicola Gökbuget, Hagop M Kantarjian, Monika Brüggemann, et al.
Blood|October 13, 2006
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 studyAdele K Fielding, Susan M Richards, Rajesh Chopra, et al.
Bone Marrow Transplantation|February 26, 2014
Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHDF L Dignan, S Aguilar, J J Scarisbrick, et al.
Bone Marrow Transplantation|September 20, 2011
Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHDF L Dignan, D Greenblatt, M Cox, et al.
Haematologica|August 4, 2009
Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remissionBella Patel, Keiren E Kirkland, Richard Szydlo, et al.
Hemasphere|June 7, 2024
Results from UKALL60+, a phase 2 study in older patients with untreated acute lymphoblastic leukemiaBela Patel, Amy A Kirkwood, Clare J Rowntree, et al.
Blood Advances|October 1, 2020
CD1a is rarely expressed in pediatric or adult relapsed/refractory T-ALL: implications for immunotherapySarah Leong, Sarah Inglott, Foteini Papaleonidopoulou, et al.
Haematologica|September 3, 2016
International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemiaNicola Gökbuget, Hervè Dombret, Jose-Maria Ribera, et al.
Pageof 17